Fiks Alexander G
LDI Issue Brief. 2014 Mar;19(1):1-4.
Despite national guidelines and proven health benefits, vaccination rates for the human papillomavirus (HPV) remain far below those of other vaccines recommended for adolescents. HPV is the most common sexually transmitted infection in the U.S; it is responsible for about 25,000 new cancers each year. A series of three shots is recommended for all girls and boys at age 11-12, but significant barriers exist to starting and finishing this series. This Issue Brief examines some of the barriers and summarizes a successful, multipronged clinical intervention to improve vaccination rates.
尽管有国家指导方针且已证实接种疫苗对健康有益，但人乳头瘤病毒（HPV）的疫苗接种率仍远低于推荐给青少年的其他疫苗。HPV是美国最常见的性传播感染疾病；每年约有25000例新癌症病例与之相关。建议所有11至12岁的女孩和男孩接种三针疫苗，但在开始和完成这一系列接种过程中存在重大障碍。本问题简报探讨了其中一些障碍，并总结了一项成功的、多方面的临床干预措施以提高疫苗接种率。
